Taysha Gene Therapies, Inc.
TSHA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001806310
In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Taysha Gene Therapies, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 155 | 2 | 195 | +42 |
| Shares | 264.6M | 3.72M | 269.0M | +8.09M (+3.1%) |
| Value | $865.6M | $12.2M | $1.48B | +$625.8M (+73.3%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (64)
Institutions that held Taysha Gene Therapies, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (22)
Institutions that held Taysha Gene Therapies, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Toronto Dominion Bank | 1,923,962 | $6.29M |
| Great Point Partners LLC | 1,500,000 | $4.91M |
| Tang Capital Management LLC | 900,000 | $2.94M |
| Alphabet Inc. | 640,882 | $2.10M |
| Anson Funds Management LP | 603,500 | $1.97M |
| Marshall Wace, LLP | 476,865 | $1.56M |
| Kovitz Investment Group Partners, LLC | 298,667 | $976.6K |
| Readystate Asset Management LP | 161,972 | $529.6K |
| Engineers Gate Manager LP | 53,483 | $174.9K |
| Jain Global LLC | 52,608 | $172.0K |
| Virtu Financial LLC | 48,123 | $157.0K |
| Quadrature Capital Ltd | 47,328 | $154.3K |
| Brevan Howard Capital Management LP | 46,643 | $152.5K |
| Sender Co & Partners, Inc. | 27,121 | $88.7K |
| DRW Securities, LLC | 16,389 | $53.3K |
| R Squared Ltd | 16,094 | $52.6K |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 12,200 | $39.9K |
| Aigen Investment Management, LP | 10,367 | $33.9K |
| FNY Investment Advisers, LLC | 4,289 | $14.0K |
| Aster Capital Management (DIFC) Ltd | 1,280 | $4.19K |
| Clearstead Advisors, LLC | 690 | $2.26K |
| Morton Brown Family Wealth, LLC | 260 | $850 |
Not filed for Q4 2025 yet (2)
Institutions that held Taysha Gene Therapies, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Tybourne Capital Management (HK) Ltd | 3,700,000 | $12.1M |
| CIBC Bancorp USA Inc. | 22,643 | $74.0K |